Skip to content

Inflammatory responses to meals with varying levels of anti-inflammatory potential: a randomised control pilot study in adults above a healthy weight

Effects of meals with varying levels of anti-inflammatory compounds on circulating cytokines in overweight and obese adults: A randomised controlled postprandial pilot study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12620000525987
Enrollment
12
Registered
2020-04-29
Start date
2018-01-02
Completion date
2018-10-26
Last updated
2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Reduction in subclinical inflammation is a potential target for chronic disease prevention, and pro-inflammatory effects of foods are observed following consumption of a single high fat meal. However, there is no consensus regarding inflammatory mediators that best characterise postprandial inflammatory responses. There are also few studies which account for the complex nutritional matrix that exists at mealtimes. Therefore, this study aims to identify whether plasma IL-6, IL-1ß, TNF-a and IL-10, the most commonly measured inflammatory mediators in postprandial research, are appropriate outcomes measures in postprandial protocols comparing acute inflammatory effects of mixed meals. In a randomised controlled, crossover design, 12 adults aged between 50 and 75 years, who are above a healthy weight, will consume three isocaloric (2.2 MJ) meals designed to have a low (-6.24), moderate (-2.76) or high (+9.36) Dietary Inflammatory Index (DII) score, after an overnight fast. Fasting and postprandial blood samples will be collected over five hours and analysed for plasma IL-6, IL-1ß, TNF-a and IL-10. Post-hoc power calculations will be used for future research, to identify appropriate outcome measures, that can be used to perform sample size calculations for larger fully-powered studies. To aid the interpretation of inflammatory responses, this study will also assess differences on postprandial glucose, insulin, lipids and subjective measures of appetite between the three test meals.

Interventions

The study uses a randomised, controlled, cross over design where participants are randomised to one of three meal orders. Each participant will attend 1 screening visit and three testing visits, with a washout period between testing visits of no less than 1 week. Screening visit (x 1): Participants will have their height, weight, waist circumference and blood pressure measured. Eligible participants will be given a physical activity questionnaire (IPAQ), a 3-day food diary, and two questionnair

The study uses a randomised, controlled, cross over design where participants are randomised to one of three meal orders. Each participant will attend 1 screening visit and three testing visits, with a washout period between testing visits of no less than 1 week. Screening visit (x 1): Participants will have their height, weight, waist circumference and blood pressure measured. Eligible participants will be given a physical activity questionnaire (IPAQ), a 3-day food diary, and two questionnaires used to explore factors that affect their food choices, to be completed prior to their first testing visit. Pre-testing procedure: Prior to each testing session participants will be provided with a ready-prepared standardised evening meal comprised of a Healthy Choice spinach and ricotta ravioli, 50 g cheese and crackers, 250 mL 100% apple juice (3MJ, 45-65% total energy (E) carbohydrate, 25-35% E protein, and 15-25% E fat). They will be asked to consume this meal between 7 – 9 pm the night before each testing day, and will be asked to fast for 12 hours prior to their test visit. During this time they will be required to refrain from eating or drinking anything else except for water until they attend the Department of Nutrition, Dietetics & Food at the BASE Facility, Monash University, Notting Hill. They will also be asked to refrain form moderate and vigorous physical activity and alcohol consumption for 24 hours prior to each testing session. To monitor adherence to pre-intervention procedures, participants will be asked to recall at what time they consumed the standardised evening meal, how much of the standardised evening meal was consumed, and any other foods or drinks consumed during the 12 hour fasting period. They will also be asked to recall all physical activity undertaken and alcohol consumed in the 24 hour period prior to their testing visits. Testing visits (x3): Participants will be asked to come in to the lab at 8 am in the morning following an overnight fast. Their weight and waist circumference will be taken. On the morning of each test session participants will have an indwelling catheter inserted and a baseline blood draw (~15ml taken at time point t = 0). Participants will then be provided with the relevant test meal, and will be supervised to ensure all of the meal is consumed within 15 minutes. They will then remain in the laboratory for five hours, during which time 8 additional blood draws (at time points t 15, 30, 45, 60, 120, 180, 240, 300 m) will be taken, and they will not be permitted to consume any food or drink except water. During each of these testing sessions participants will also be asked to complete 3 visual analogue scales (VAS) for hunger, desire to eat, and fullness. These three VAS scales will be completed at baseline (before consuming the test meal) and then hourly for five hours (at time points t 60, 120, 180, 240 and 300 m). Lastly, participants will be asked to undertake two questionnaires about sensory evaluation and factors affecting their likelihood to prepare each of the test meals at home. Following the final blood draw the indwelling catheter will be removed. During the first testing visit participants will have their body composition (DXA scan) measured. The DXA scan will be performed prior to catheter insertion. A qualified dietitian will also take a detailed diet history. Test Meals: There are three isocaloric test meals (2.2 MJ) meals designed to have a low (-6.24, termed the anti-inflammatory meal), moderate (-2.76, termed the neutral meal) or high (+9.36, termed the pro-inflammatory meal) Dietary Inflammatory Index (DII) score. The pro-inflammatory meal, a cheese and bacon croissant, is a highly processed meal obtained from commercially available products. The neutral meal, a chicken, vegetable, red kidney bean and wholegrain pasta minestrone soup, is a typical healthy meal. The anti-inflammatory meal is an adaptation of the neutral meal, specifically designed to optimise purported anti-inflammatory compounds, including but not limited to ß-carotene, eugenol, fibre, omega-3 fatty acids, vitamin A, vitamin E and flavonoids. The anti-inflammatory meal is the intervention meal and can be described as a chicken, vegetable and red kidney bean curry, served with brown rice, flaxseeds, and a lemon kefir yogurt (2.3 MJ, with 36% energy from carbohydrate (19 g fibre), 35% energy from fat (3.4 g saturates) and 19% energy from protein).

Sponsors

Dr Aimee Dordevic
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Eligible participants were men > 50 and < 75 years or post-menopausal women, with a body mass index (BMI) > 25 kg/m2.

Exclusion criteria

Diagnosis of a chronic disease (such as CVD or T2DM), known allergies/intolerances to study foods, loss of > 10% total body weight in the 6 months preceding the study, smokers, history of drug or alcohol addiction, and use of anti-inflammatory medications such as aspirin, steroids or non-steroidal anti-inflammatory drugs.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026